Post-approval studies (Phase 4)Study completedNCT01437982
What this trial is testing
Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
Who this might be right for
Conjunctivitis, Seasonal AllergicConjunctivitis, Giant PapillaryInflammation
Bausch & Lomb Incorporated 140